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INTRODUCTION
Tobacco smoking has been identified as the leading 
cause of preventable deaths worldwide. This is a cause 
for alarm as the number of smokers has been 
increasing worldwide especially in the developing 
countries and among women [1]. Smoking has been 
linked to pregnancy-related complications, cancer of 
the female reproductive organs and menstrual 
dysfunctions [2]. Nicotine in tobacco smoke has been 
shown to adversely affect female reproduction in 
almost all stages of reproductive processes including 
folliculogenesis, embryo transport, endometrial 
receptivity, steroidogenesis and even menopause [3]. 
Nicotine exposure during pregnancy increases the risk 
of foetal mortality and morbidity [4]. In humans, 
smoking and nicotine has been associated with an 
increase in the number of spontaneous abortions [5]. 
Foetal loss before 20 weeks of gestation was found to 
be 33% higher among smokers compared to that of 
non-smokers [6]. There was also an increased risk of 
abruptio placenta [7], per vaginal bleeding during 
pregnancy, premature rupture of membranes [8], 
preterm delivery [5] and stillbirth [4] among women 
who smoke during pregnancy.  The increased risk of 
spontaneous abortion may be attributed to the effects 
of nicotine on the embryo transfer process, 
fertilization, implantation or placentation.  Nicotine 
exposure during pregnancy has also been associated 
with low birth weight of the infants [9]. The low-birth 
weight of infants in nicotine-exposed mothers might be 
attributed to the effects of nicotine on fetal growth in 
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utero and on the placenta [9]. Nicotine has also been 
shown to disrupt the pattern of maternal plasma 
progesterone and oestrogen levels. Plasma 
progesterone level was reported to be significantly 
decreased during the first trimester in rats following 
nicotine administration [10]. However, conflicting 
reports exist on the effect of nicotine on the level of 
oestrogen; with some studies reporting a decrease [11, 
12]; while others suggesting an increase [13, 14] in its 
level. 
Exposure of nicotine during differing 
gestational periods yield differing outcomes [15]. In 
the current study, nicotine administration was 
scheduled in three different timeframes in relation to 
the decidualization of the endometrium, namely: 
period of endometrial sensitivity, period of 
endometrial growth and periods of both endometrial 
sensitivity and growth [16]. 
Another question is, although nicotine has 
been shown to have detrimental effects on foetal 
development, it is unclear as to during which stage of 
pregnancy that these effects are more severe. 
Subsequently, it is also unclear if foetuses exposed to 




Female Sprague-Dawley rats weighing 180-220g with 
regular 4-day oestrous cycle were used in this study. 
Animals had free access to laboratory chow and 
drinking water. The room temperature was kept at 25° 
C with a 12:12 hour light: dark cycle. The study design 
was approved by the Committee on Animal Research 
and Ethics, UiTM (approval code). 
Experimental Design 
Upon confirmation of pro-oestrous via a vaginal 
smearing, animals were randomized into eight groups 
and housed individually with a fertile male overnight. 
The presence of sperm in the vaginal smear the 
following morning confirmed positive mating and was 
considered as day 1 of pregnancy. Treatment was 
scheduled in three different timeframes as shown in 
Table 1, namely: period of endometrial sensitivity, 
which coincided with treatment from Day 1 to Day 5 
of pregnancy, period of endometrial growth (from Day 
5 to Day 9 of pregnancy) and both periods of 
endometrial sensitivity and growth together, which 
encompassed treatment from Day 1 to Day 9 of 
pregnancy [16]. Nicotine tartrate (Sigma-Aldrich, 
USA) solution with a concentration of 7.5 mg/kg was 
injected subcutaneously (sc) at the back of the neck 
[17] twice a day (at 0900 and 1600 hours) (Table 1). 
Control animals received equivalent volume of normal 
saline subcutaneously. On day 10 of pregnancy, the 
animals were anaesthetized with an intraperitoneal 
injection of a mixture of Ketamine (250 mg/5ml), 
Xylazine (20 mg) and Zoletil (50 mg) at a dose of 0.1 
ml/100g body weight.  Laparotomy was performed, the 
uterine horns were exposed, and the number of 
implantation sites counted. The site of incision was 
then sutured in layers using absorbable suture (Catgut 
2.0) for the muscle and non-absorbable suture (Nylon 
2.0) for the skin. The animals were allowed to recover 
and observed on a daily basis. On day 16 of 
pregnancy, animals in groups 4a and 4b were 
anaesthetised and blood was collected via cardiac 
puncture for oestrogen and progesterone estimation.  
The rats were then euthanised, and laparotomy was 
performed to remove the uterine horns. The foeto-
placental unit was removed together with the overlying 
uterine tissue and weighed. The remaining groups of 
rats were allowed to go till term and daily inspection 
was done to see evidence of foetal expulsion and also 
to monitor the duration of pregnancy. Immediately 
following parturition, the number of pups delivered 
was counted and the birth weight of each pup was 
recorded. Foetal loss was calculated as the difference 
between the number of viable implantation sites on 
day 10 of pregnancy and the number of pups delivered. 
The weight of the pups was recorded every other day 
until weaning (post-natal day 21). 
Table 1 Treatment schedules during pregnancy in control and nicotine-treated 
rats (n=6 for each group) 
Group Type of Treatment Duration of Treatment 
   
1a Nicotine tartrate 7.5mg/kg/day Days 1 to 5 of pregnancy 
1b 0.9% normal saline Days 1 to 5 of pregnancy 
   
2a Nicotine tartrate 7.5mg/kg/day Days 5 to 9 of pregnancy 
2b 0.9% normal saline Days 5 to 9 of pregnancy 
   
3a Nicotine tartrate 7.5mg/kg/day Days 1 to 9 of pregnancy 
3b 0.9% normal saline Days 1 to 9 of pregnancy 
   
4a Nicotine tartrate 7.5mg/kg/day Days 1 to 9 of pregnancy 
4b 0.9% normal saline Days 1 to 9 of pregnancy 
(sacrificed on day 16 of 
pregnancy 
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Blood samples collected from animals in groups 4a 
and 4b were centrifuged at 3000 rpm for 15 minutes 
and stored at -80ºC. Oestrogen and progesterone 
estimation in plasma was done using the automated 
electrochemiluminescence immunoassay (ECLIA) 
technique (Roche Elecsys, Switzerland). 
Statistical Analysis 
Normality of the data distribution was assessed using 
Kolmogorov-Smirnov test. Normally distributed data 
were analyzed using t-test and the data were expressed 
as mean ± SEM.   Skewed data were analyzed using 
Mann-Whitney test and expressed as median 
(interquartile range, IQR). Chi square test was used to 
test categorical variable. Statistical significance was 
defined as p<0.05 and all the statistical analyses were 
performed using statistical test contained in the SPSS 
19.0 software. 
RESULTS 
There was no significant difference in the duration of 
pregnancy between the control and all the nicotine-
treated groups (Table 2). 
 
Table 2 Duration of pregnancy (days) in control and nicotine-treated 
groups 
Groups 
Pregnancy duration (days) 
1a and 1b, 
median (IQR) 
2a and 2b, 
median (IQR) 
3a and 3b, 
median (IQR) 
    
Nicotine-treated 23.00 (0) 23.00 (1) 23.00 (0) 
Control 23.00 (0) 23.00 (0) 23.00 (0) 
Z -0.114 -1.363 -0.935 
P value NS NS NS 
    
NS = not significant 
 
There was no significant difference in the 
number of blastocyst implantation sites on day 10 of 
pregnancy between the nicotine-treated groups and 
their respective controls (Table 3). 
 
Table 3 Number of blastocyst implantation sites on day 10 of pregnancy in 
control and nicotine-treated groups. 
Groups 
Number of blastocyst implantation sites on day 10 of 
pregnancy  
1a and 1b, 
mean ± (SEM) 
2a and 2b, 
mean ± (SEM) 
3a and 3b, 
mean ± (SEM) 
    
Nicotine-treated 10.67 ± 0.57 10.83 ± 0.65 9.57 ± 0.53 
Control 11.67 ± 0.56 11.67 ± 0.55 11.29 ± 0.61 
t (df) 1.268 (10) 0.969 (10) 2.132 (12) 
P value NS NS NS 
NS = Not significant 
 
 
Foetal loss was significantly greater in the 
groups receiving nicotine from days 5 to 9 of 
pregnancy (p<0.001) and from days 1 to 9 of 
pregnancy (p<0.001) when compared to their 
respective controls. In the group that received nicotine 
from days 5 to 9 of pregnancy, fetal loss was 3.805 
times greater than that in the control.  Whereas the 
group that received nicotine from days 1 to 9 of 
pregnancy, the loss was 4.324 times greater than that 
in the control (Table 4). 
 

















      
1a 64 52 12 0.591 NS 
1b 75 66 9 (0.231, 
1.509) 
 
      
2a 65 41 24*** 3.805 <0.001 
2b 75 65 10 (1.651, 
8.768) 
 
      
3a 67 41 26*** 4.324 <0.001 
3b 86 75 11 (1.940, 
9.634) 
 
      
(Pearson chi-square, ***p<0.001) 
 
On day 16 of pregnancy, significant foetal loss 
was evident in animals treated with nicotine when 
compared to that in its control (p value = 0.008). The 
loss was 2.86 times higher [OR=2.862 
(95%=1.294,6.332)] (Table 5). 
 
Table 5 Number of viable pups and foetal loss at day 16 of pregnancy in 
control and nicotine-treated groups 
 Day 10 of 
pregnancy 














      
4a 54 29 25** 2.86 0.008** 
4b 68 57 11 (1.294, 
6.332) 
 
      
 
The weight of the foeto-placental unit on day 
16 of pregnancy was significantly lower in nicotine-
treated rats when compared to that in gestation-
matched controls (p<0.001; Table 6). 
 
Table 6 Weight of the foeto-placental unit/swelling (g) on day 16 of 
pregnancy in groups 4a and 4b 
Group Weight of the foeto-
placental unit/swelling (g), 
mean ±SEM 
t (df) p value 
    
Nicotine-treated 0.99 ± 0.02*** 3.911 
(119) 
<0.001 
Control 1.08 ± 0.01 
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Birth weight of the pups in all the three 
nicotine-treated groups was significantly lower when 
compared to their respective controls. However, this 
pattern of lower weight did not continue until weaning.  
On day 21 post-natal, the weight of the pups in all 
three nicotine-treated groups was not different from 
their respective controls as shown in Table 7. 
 
Table 7 Weight of the pups (g) at birth and at day 21 post-natal in control and 
nicotine-treated group 
Groups 
Pups weight (g) 
1a and 1b 
(median, IQR) 
2a and 2b 
(median, IQR) 
3a and 3b, median 
(IQR) 
 At Birth Day 
21 
At Birth Day 
21 




























Z -6.279 -1.870 -3.669 -0.318 -5.493 -1.679 
p value <0.001 NS <0.001 NS <0.001 NS 
    
 
Compared to that in the controls, plasma 
oestrogen level on day 16 of pregnancy was 
significantly higher in animals treated with nicotine 
from day 1 to 9 of pregnancy (p<0.01), whereas the 
progesterone level was significantly lower in nicotine-
treated animals when compared to that in the control 
(Table 8). 
 
Table 8 Plasma oestrogen (pmol/L) and progesterone (nmol/L) levels on 
day 16 of pregnancy in rats given nicotine from day 1 to day 9 of 
pregnancy 
Group Plasma level of 
oestrogen (pmol/L), 
mean ± SEM 
Plasma level of 
progesterone (nmol/L), 
mean ± SEM 
   
Nicotine-treated 103.64 ± 6.24** 341.27 ± 25.15* 
Control 77.33 ± 5.37 419.00 ± 26.14 
t (df) -3.197 (26) 2.143 (16) 
p value <0.01 <0.05 
   
 
DISCUSSION 
The present study demonstrates that nicotine 
significantly: 1) increased fetal loss, particularly when 
exposed to nicotine from day 5 to day 9 of pregnancy 
and day 1 to day 9 of pregnancy and 2) lowered the 
birth weight of pups. The detrimental effect of nicotine 
is usually dose-dependent and depends on the duration 
of exposure [18]. These findings may be attributed to 
nicotine’s detrimental action on the growth of the 
placenta. Nicotine exposure in pregnant rats was 
shown to cause vasoconstriction of uterine arteries 
which disrupted the uterine circulation, resulting in 
reduction of blood flow [19]. A sufficient flow to the 
uteroplacental vessels is very important to achieve a 
normal pregnancy outcome. Haemodynamic changes 
in the maternal uterine circulation are characterized by 
a significant decrease in the resistance of the uterine 
vessels, which in turn, is due to vessel growth and 
vasodilation [20].  It was reported in rats that 
intrauterine growth restriction was associated with 
altered utero-placental perfusion [21]. These may 
explain the increased number of foetal loss during 
parturition (Table 4) and the decreased weight of the 
uteroplacental swelling on day 16 of pregnancy (Table 
6). The number of foetal loss is significantly higher in 
groups treated with nicotine from day 5 to day 9 of 
pregnancy when compared to that of groups treated 
with nicotine from day 1 to day 5 of pregnancy. This 
finding may be due to the fact that in rats, implantation 
and thus growth of placental layers and structures only 
begin after day 5 of pregnancy. Thus, the 
decidualization of stroma following implantation only 
begin on day 4 or day 5 of pregnancy [22]. 
The present study also showed that nicotine 
reduces the birth weight of the pups, possibly via its 
detrimental effect on the placenta, and subsequently 
fetal growth is restricted. This low birth weight pups 
may also be attributed to the action of nicotine on 
maternal food intake. The exact mechanism of low 
maternal food intake is unknown but it was shown that 
nicotine activated the pro-opiomelanocortin (POMC) 
neurons which is responsible for stimulating the satiety 
center [23]. Nicotine administration has also been 
shown to increase the level of corticotropin-releasing 
hormone (CRH) [24], which will also stimulate the 
satiety center. It leads to decreased food intake and the 
subsequent low body weight may contribute to low 
birth weight infants. 
Although the birth weight of pups significantly 
decreases following nicotine administration, there was 
a catch-up growth in early infancy as shown in the 
postnatal weight at day 21. This catch-up growth may 
be due to the effect of nicotine on metabolic changes. 
Exposure to nicotine during the perinatal stage was 
shown to cause an increase in body weight and fat 
mass in adult male rats despite having no change in the 
food intake [25]. This was attributed to the effect of 
nicotine in altering early adipogenesis [25]. Several 
epidemiological studies [26, 27] have reported the 
association between maternal smoking and increased 
weight of the offsprings during childhood with an 
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increased risk of developing obesity and hypertension 
in later life [28].  However, the exact mechanism in 
human was unknown. 
Apart from its detrimental effects on the 
placenta, nicotine may also directly affect the fetus. 
This possibility was based on the study by Zhao and 
Reece [29] who showed that nicotine caused various 
developmental abnormalities. They found that murine 
embryo cultures treated with nicotine resulted in 
abnormalities such as opened neural tube in the 
anterior regions with opened forebrain and hindbrain, 
both of which are incompatible with life [29].  There 
was also developmental retardation as evidenced by 
shorter crown/rump length [29]. They attributed these 
findings to the increased level of intracellular Ca2+ 
and oxidative stress following nicotine treatment [29]. 
In the current study, nicotine significantly 
increased the level of maternal plasma oestrogen 
(Table 8). An increase in the level of circulating 
maternal oestrogen may have also contributed to the 
increased foetal loss. It was reported by 
Bartholomeusz et al [30] and Matsuura et al [31] that 
high dosage of oestrogen given to pregnant rats 
resulted in reduced survival of the foetus. They 
reported that even minor elevation of maternal 
oestrogen during mid-gestation may elicit foetal death. 
The exact mechanism by which this foetal loss occurs 
due to increased oestrogen level is still unclear but it 
may be attributed to the effects of oestrogen on the 
reduced density of the foetal blood vessels [30]. 
Oestrogen also has a direct effect on the uterus. It is 
known that oestrogen promotes uterine contraction 
[32] as seen during parturition. The increased uterine 
contraction before parturition may lead to premature 
foetal expulsion and loss. 
It is tempting to suggest that the increased 
oestrogen coupled with low progesterone level found 
in this study (Table 8) may explain the high foetal loss. 
Progesterone is an essential hormone to maintain 
uterine function during pregnancy. Nicotine was 
shown to distort the ovarian cytoarchitecture which 
may affect the progesterone level during early 
pregnancy [10]. Progesterone also promotes 
myometrial relaxation during early pregnancy, and 
withdrawal of this hormone has been shown to initiate 
parturition [33]. Decreased maternal progesterone has 
also been shown to retard placental and foetal growth, 
especially in the placental basal zone, and 
subsequently affect the survival of the fetus [34]. 
This interplay of oestrogen and progesterone is 
also important in decidualization in the rats, and 
formation of the maternal part of the placenta [35]. It 
was shown that the combination of decreased level of 
progesterone with increased level of oestrogen may 
compromise the growth of the decidua cells [36]. The 
compromised decidualization will affect the growth 
and development of the foetus and may lead to an 




The foetal loss and low foetal birth weight observed in 
the present study appears to be partly due to altered 
plasma levels of oestrogen and progesterone following 
nicotine administration. 
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